Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Daily eggs boost baby brains and bodies in guatemala study

NCT ID NCT04316221

Knowledge-focused Sponsor: Academy of Nutrition and Dietetics Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether giving eggs every day to babies around 6 months old helps them grow and develop better. About 1,200 infants in Guatemala took part. Half got eggs plus standard nutrition advice, and the other half got only the advice. The researchers measured development, growth, and diet quality to see if eggs made a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,200 people

The number who actually took part.

Started

Apr 2021

Finished

Sep 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 9 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Infants who are 6.0-9.0 months of age at baseline * At least one caregiver willing to provide oral informed consent * Planned residence in the study area for approximately the next 18 months * Singleton birth Exclusion Criteria: * Infants with moderate to severe acute malnutrition (weight-for-length z-score \< -2) * Infants with severe anemia (Hgb \<7 g/dL per WHO guidelines, with adjustments for altitude as necessary) * Infants with a chronic medical condition that affects growth (e.g., congenital heart disease, genetic condition) as determined by the MHA staff physician * Infants whose caregivers have cognitive or other impairments that prevent them from being able to provide informed consent or to reliably provide information required for the developmental assessments * Infants with a known egg allergy * Infants with recalcitrant, moderate-to-severe atopic dermatitis * Infants with a history of anaphylaxis or serious allergic reaction to any substance requiring emergency medical care * Concurrent participation in any other clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Development; delayed are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Development; delayed GROWTH

Contacts and locations

Locations

  • Wuqu' Kawoq/Maya Health Alliance

    Tecpán Guatemala, Departamento de Chimaltenango, Guatemala

More trials for these conditions

Other studies related to the condition(s) this trial covers.